Health Care

Trials Show Inactivated Zika Virus Vaccine is Safe and Immunogenic

Trials Show Inactivated Zika Virus Vaccine is Safe and Immunogenic”

"In addition, NIAID is helping to develop an investigational mRNA Zika vaccine and a live-attenuated vaccine candidate created to protect against Zika and all 4 strains of dengue virus".

Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response.

The second study tested two forms of a DNA-based vaccine created by NIAID scientists soon after reports surfaced linking Zika infection during pregnancy to birth defects. Of these 67 participants, a total of 55 received 2 intramuscular injections of the investigational vaccine at the same dosage each time, 4 weeks apart, while the remaining 12 participants received a placebo, at the same dosing parameters, according to a press release on the study. After the initial injection, the adults were given another dose four weeks and then eight weeks later.

"Zika remains a threat to USA military personnel and families of service members".

The ZPIV vaccine, made from inactivated Zika virus particles, was developed by US Army researchers, who in July previous year had agreed to give Sanofi an exclusive licence to complete testing and bring the product to market. They found this vaccine also produced an immune response, but it was not as strong. Each received either two or three 4-mg doses at various time intervals.

They found that 60 to 89 per cent of participants generated a neutralising antibody response to VRC5288, whereas 77 to 100 per cent of participants generated a neutralising antibody response to VRC5283.

To measure the effectiveness of the immune response, researchers extracted antibodies from the participants and injected them into mice.

Investigators announced that VRC5283 was advanced to a phase II trial in March 2017 that aims to enroll around 2,500 healthy participants ages 15 to 35 from the U.S., Puerto Rico, and Central and South America.

They wrote said the results from both trials are promising, but more research is needed to address key questions. The mice were purposefully infected with Zika virus.

Also, they raised concerns about the possibility of whether immunity to Zika from vaccination may alter the behavior of other flaviviruses, such as dengue viruses or dengue vaccination, which could have a clinical impact.

While Zika experts have not precisely determined the concentration of antibodies needed to protect against congenital infection, animal model studies are helping to provide useful insights. They noted that it took almost 30 years for a rubella vaccine to become available, and though Zika incidence has dropped in most countries, its spread has been wide and unpredictable.



Like this

Latest


06 December 2017
The Favorable Media Coverage Likely to Impact Dynegy (DYN) Share Price
Among 14 analysts covering Dynegy (NYSE: DYN ), 7 have Buy rating, 1 Sell and 6 Hold. (NYSE: DYN ) rating on Sunday, October 8. At the same time, the volatility-measuring Average True Range (ATR) for this stock is 0.1275, suggesting High Volatility.

06 December 2017
Minnesota faces $188 million budget deficit
But he cautioned lawmakers against tapping a $1.6 billion budgetary reserve to solve a budget shortfall. Minnesota lawmakers will have to fill a projected $188 million budget deficit next year.

06 December 2017
What the new tax plan means for students
The Senate, which approved its tax reform package early Saturday morning, did not touch the graduate tuition exemption. Congress is beginning work on a compromise between the two separate tax plans passed by the House and Senate.

06 December 2017
Matt Smith feels sorry for Meghan Markle
While Meghan Markle has become the princess of influence overnight, she may have a thing or two to learn about royal protocol. The 35-year-old actor says he feels "sorry" for Meghan as her life is never going to be the same again.

06 December 2017
Active Volume Stock: Caterpillar Inc. (NYSE:CAT)
Baker Ellis Asset Management LLC acquired a new stake in Caterpillar during the 2nd quarter valued at $104,000. (NYSE:CAT). Citigroup maintained the stock with "Neutral" rating in Wednesday, July 26 report. (NYSE:CAT) for 208,676 shares.

06 December 2017
Guardiola Welcomes Fergie time After Another City Late Show
Manchester City will go into next week's hotly anticipated Derby against Manchester United eight points clear at the top of the Premier League .

06 December 2017
How Analysts Feel About Francesca's Holdings Corporation (NASDAQ:FRAN)?
KeyBanc Capital Markets maintained Francesca's Holdings Corporation (NASDAQ: FRAN ) on Monday, September 25 with "Hold" rating. The stock of Francesca's Holdings Corporation (NASDAQ: FRAN ) earned "Neutral" rating by Mizuho on Thursday, January 7.

06 December 2017
Coroner called to scene of pipeline explosion
Police say neighbors aided the two victims and took them to a local hospital from where they then flown to Rockford. At this time investigators have not confirmed what led to the explosion near the area of Nachusa Road and Route 38.

06 December 2017
Patriots' Gronkowski suspended one game for late hit
Gronkowski was fined $8,268 in 2015 for fighting near the end of the Patriots' Super Bowl XLIX victory over the Seattle Seahawks. Zolak thought that White was holding on the play and that somehow excused Gronkowski's retaliation. "To me, it was blatant".

06 December 2017
Capcom reveals details of Street Fighter V Arcade Edition's Arcade Mode
Those at PlayStation Experience can play the Arcade Mode at the event, but the rest of us will have to wait until January. These points will then be tallied up each month with the highest scoring player earning themselves unique a Title.



Recommended